Tokyo, April 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060599) titled 'Evaluation of the Acceptability of Endoscopic Gastric Cancer Screening' on April 1.

Study Type: Observational

Primary Sponsor: Institute - International University of Health and Welfare Ichikawa Hospital

Condition: Condition - Gastric cancer Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - In Japan, endoscopic screening has been implemented as a population-based gastric cancer screening program since 2016, following the revision of the Ministry of Health, Labour and Welfare guidelines. The program targets adults aged 50 years or older, with biennial screening recommended. However, limited availability of medical institutions capable of providing endoscopic screening has prevented some municipalities from offering screening to all eligible residents. Moreover, the prevalence of Helicobacter pylori infection, a major risk factor for gastric cancer, has been declining, particularly among younger generations, potentially reducing the effectiveness and cost-effectiveness of the current screening strategy. Therefore, optimizing both screening strategies and delivery systems may require increasing the starting age or extending the screening interval to reduce the required number of endoscopic examinations. This study aims to assess screening participants' understanding, satisfaction, and acceptance of potential changes to the current gastric cancer endoscopic screening strategy through a questionnaire survey conducted in Japanese municipalities. Basic objectives2 - Efficacy

Eligibility: Age-lower limit - 50 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Residents applying for gastric cancer endoscopic screening in Fuchu City, Tokyo and Ichikawa City, Chiba Prefecture, in fiscal year 2026 Key exclusion criteria - 1. Individuals who do not consent to the questionnaire survey 2. Individuals who have undergone total gastrectomy 3. Individuals who undergo regular upper gastrointestinal endoscopy for any reason 4. Individuals with bleeding tendencies or suspected bleeding tendencies 5. Individuals with severe diseases of the pharynx, nasal cavity, etc., preventing endoscope insertion 6. Individuals with respiratory failure 7. Individuals whose general condition is deemed too poor to tolerate endoscopy 8. Individuals currently hospitalized, regardless of the type of disease Target Size - 1000

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2025 Year 11 Month 18 Day Date of IRB - 2025 Year 11 Month 25 Day Anticipated trial start date - 2026 Year 04 Month 01 Day Last follow-up date - 2027 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069316

Disclaimer: Curated by HT Syndication.